These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 26823130

  • 1. Impact of serous retinal detachment on the efficacy of ranibizumab in diabetic macular oedema.
    Qu-Knafo LM, Fajnkuchen F, Sarda V, Boubaya M, Levy V, Chaine G, Giocanti-Auregan A.
    Acta Ophthalmol; 2017 Aug; 95(5):e434-e435. PubMed ID: 26823130
    [No Abstract] [Full Text] [Related]

  • 2. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
    Santos AR, Alves D, Santos T, Figueira J, Silva R, Cunha-Vaz JG.
    Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
    [Abstract] [Full Text] [Related]

  • 3. Refractive changes after intravitreal ranibizumab injections for diabetic macular oedema.
    Chatziralli I, Chatzipantelis A, Dimitriou E, Mpourouki E, Theodossiadis G, Theodossiadis P.
    Clin Exp Optom; 2018 May; 101(3):397-399. PubMed ID: 29134696
    [Abstract] [Full Text] [Related]

  • 4. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
    Vujosevic S, Torresin T, Bini S, Convento E, Pilotto E, Parrozzani R, Midena E.
    Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
    [Abstract] [Full Text] [Related]

  • 5. Comparison of two individualized treatment regimens with ranibizumab for diabetic macular edema.
    Ebneter A, Waldmeier D, Zysset-Burri DC, Wolf S, Zinkernagel MS.
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):549-555. PubMed ID: 27714513
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG, Loewenstein A, Patel SS, Massin P, Corcóstegui B, Li XY, Jiao J, Hashad Y, Whitcup SM.
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [Abstract] [Full Text] [Related]

  • 12. A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS).
    Stefanickova J, Cunha-Vaz J, Ulbig M, Pearce I, Fernández-Vega Sanz A, Theodossiadis P, Kodjikian L, Izmailov A, Muston D, Vassilev Z, Lamotte B, Tückmantel C, Friedl S, Altemark A, Schwarz HJ, Katz T, POLARIS study investigators.
    Acta Ophthalmol; 2018 Dec; 96(8):e942-e949. PubMed ID: 29696809
    [Abstract] [Full Text] [Related]

  • 13. Relationship Between Final Visual Acuity and Optical Coherence Tomography Findings in Patients with Diabetic Macular Edema Undergoing Anti-VEGF Therapy.
    Eraslan S, Yıldırım Ö, Dursun Ö, Dinç E, Orekici Temel G.
    Turk J Ophthalmol; 2020 Jun 27; 50(3):163-168. PubMed ID: 32631004
    [Abstract] [Full Text] [Related]

  • 14. OCT Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema.
    Hsieh YT, Alam MN, Le D, Hsiao CC, Yang CH, Chao DL, Yao X.
    Ophthalmol Retina; 2019 Oct 27; 3(10):826-834. PubMed ID: 31227330
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANALYSIS OF RETINAL DEGENERATIVE CHANGES IN DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Boiko EV, Maltsev DS.
    Retina; 2018 Jul 27; 38(7):1324-1330. PubMed ID: 28492427
    [Abstract] [Full Text] [Related]

  • 17. Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema: A Subanalysis of the RESTORE (Extension) Study.
    Karst SG, Deak GG, Gerendas BS, Waldstein SM, Lammer J, Simader C, Guerin T, Schmidt-Erfurth UM.
    JAMA Ophthalmol; 2018 Apr 01; 136(4):315-321. PubMed ID: 29494727
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the New "SAVE" Protocol in Diabetic Macular Edema Over the Course of Anti-VEGF Treatment.
    Reznicek L, Bolz M, Garip A, Kampik A, Kernt M, Mayer WJ.
    Curr Eye Res; 2016 Aug 01; 41(8):1082-1086. PubMed ID: 26580417
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.